ALSGD.PA • EURONEXT
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold ALSGD.PA in your mock portfolio yet.
The negative EPS and corresponding negative P/E ratio indicate that SpineGuard SA is currently unprofitable. With no evidence of positive earnings momentum in the data provided, the company appears to be struggling to generate net income. Profitability remains the key overhang for the equity story.
The stock trades at €0.11 and is down a modest 0.9% over the last month, indicating relative price stability rather than a sharp selloff or rally. The RSI at 61.50 is in the upper neutral range, suggesting neither overbought nor oversold conditions, while the 200-day moving average at €0.11 shows the price is roughly in line with its longer-term trend. Overall, technicals point to a consolidating stock with no strong directional signal.
Alternative data suggest limited growth momentum in SpineGuard SA’s broader business footprint. Website traffic is modest at around 3,550 visitors per month, and hiring activity is flat with zero job openings, which typically does not signal aggressive expansion. Social media followings are small and largely stagnant, pointing to low brand engagement and limited organic interest.
Overall, SpineGuard SA’s investment profile appears bearish at this stage. Persistent unprofitability, modest and stagnant alternative data signals, and only neutral technicals combine to suggest limited near-term upside. Without clear evidence of improving earnings or accelerating business activity, the risk/reward skews unfavorably.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: